Works matching IS 15391604 AND DT 2023 AND VI 22 AND IP 3
Results: 13
Principled leveraging of external data in the evaluation of diagnostic devices via the propensity score‐integrated composite likelihood approach.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 547, doi. 10.1002/pst.2295
- By:
- Publication type:
- Article
Re‐randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 570, doi. 10.1002/pst.2290
- By:
- Publication type:
- Article
Bayesian hierarchical models for adaptive basket trial designs.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 531, doi. 10.1002/pst.2289
- By:
- Publication type:
- Article
A fiducial approach for testing the non‐inferiority of proportion difference in matched‐pairs design.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 520, doi. 10.1002/pst.2288
- By:
- Publication type:
- Article
Statistical considerations for assessing precision of heterogeneous duplicate measurements: An application to pharmaceutical bioanalysis.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 461, doi. 10.1002/pst.2282
- By:
- Publication type:
- Article
Improving early phase oncology clinical trial design: An opportunity for statisticians.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 577, doi. 10.1002/pst.2287
- By:
- Publication type:
- Article
Natural cubic splines for the analysis of Alzheimer's clinical trials.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 508, doi. 10.1002/pst.2285
- By:
- Publication type:
- Article
An improved score‐type confidence interval for stratified risk differences involving rare events.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 492, doi. 10.1002/pst.2284
- By:
- Publication type:
- Article
Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 475, doi. 10.1002/pst.2283
- By:
- Publication type:
- Article
Just say no to data listings!
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 581, doi. 10.1002/pst.2286
- By:
- Publication type:
- Article
Parametric and nonparametric methods for confidence intervals and sample size planning for win probability in parallel‐group randomized trials with Likert item and Likert scale data.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 418, doi. 10.1002/pst.2280
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 415, doi. 10.1002/pst.2237
- Publication type:
- Article
Incorporating historical information to improve dose optimization design with toxicity and efficacy endpoints: iBOIN‐ET.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 440, doi. 10.1002/pst.2281
- By:
- Publication type:
- Article